Myosin Ie Inhibitors constitute a distinct and noteworthy subset within the realm of chemical compounds, celebrated for their intricate influence on the activity of the protein Myosin Ie. This chemical class is notably characterized by its capacity to intricately modulate the nuanced operations of Myosin Ie, an essential motor protein acclaimed for its pivotal involvement in a multitude of intricate cellular processes. Chief among its responsibilities is the orchestration of cellular movement and transport, wherein it orchestrates the transportation of cellular components along actin filaments. This dynamic functionality culminates in its pivotal contributions to essential cellular phenomena, including intracellular conveyance, cell migration, and the preservation of cellular morphology. At the crux of the matter lies the modus operandi of these inhibitors-a mechanism that hinges on their remarkable affinity for specific binding sites on the Myosin Ie protein. Through this engrossing interaction, these inhibitors intricately alter the conformation of Myosin Ie, thereby instigating a cascade of repercussions that cascade throughout the cellular landscape.
The consequential perturbations manifest as a disruption in Myosin Ie's interactions with other integral cellular constituents, thereby inevitably reverberating into the very core of the cellular processes reliant upon Myosin Ie's characteristic motor activity. The allure of these inhibitors lies not only in their proclivity to intricately meddle with Myosin Ie's functionality but also in their nuanced selectivity. This specificity empowers researchers and scientists, offering them a powerful tool to navigate the labyrinthine corridors of cellular dynamics. These inhibitors, by virtuously targeting the Myosin Ie protein, pave the way for revelations surrounding the intricate choreography of cellular motion, the orchestration of molecular traffic, and the nuances of cell shape modulation.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
(±)-Blebbistatin | 674289-55-5 | sc-203532B sc-203532 sc-203532A sc-203532C sc-203532D | 5 mg 10 mg 25 mg 50 mg 100 mg | $183.00 $313.00 $464.00 $942.00 $1723.00 | 7 | |
Inhibits non-muscle myosin II ATPase activity by binding to the ATPase pocket. | ||||||
Y-27632, free base | 146986-50-7 | sc-3536 sc-3536A | 5 mg 50 mg | $186.00 $707.00 | 88 | |
Selective inhibitor of Rho-associated protein kinase (ROCK), affecting myosin II through actin cytoskeletal dynamics. | ||||||
ML-7 hydrochloride | 110448-33-4 | sc-200557 sc-200557A | 10 mg 50 mg | $91.00 $267.00 | 13 | |
Inhibitor of myosin light chain kinase (MLCK), reducing myosin II activity by impacting phosphorylation of myosin light chain. | ||||||
ML-9 | 105637-50-1 | sc-200519 sc-200519A sc-200519B sc-200519C | 10 mg 50 mg 100 mg 250 mg | $112.00 $449.00 $673.00 $1224.00 | 2 | |
Similar to ML-7, inhibits myosin light chain kinase to influence myosin II activity. | ||||||
Cytochalasin D | 22144-77-0 | sc-201442 sc-201442A | 1 mg 5 mg | $165.00 $486.00 | 64 | |
Disrupts actin polymerization, indirectly affecting myosin II through the actin cytoskeleton. | ||||||
Calpeptin | 117591-20-5 | sc-202516 sc-202516A | 10 mg 50 mg | $121.00 $456.00 | 28 | |
Calpain inhibitor preventing calpain-mediated cleavage of myosin regulatory light chains. | ||||||